Small molecule screen in embryonic zebrafish using modular variations to target segmentation.

Area of Science:

• Developmental biology
• Pharmacology
• Genetics

Background:

• In vivo phenotypic screening identifies drug effects in living organisms but can miss compounds due to false negatives.
• Current screening designs may not fully utilize chemical library potential for discovering novel therapeutics.

Purpose of the Study:

• To develop and validate a modular small molecule screening strategy in zebrafish.
• To improve the recovery of bioactive compounds for segmentation disorders and other developmental defects.
• To identify novel molecular pathways and phenotypes associated with vertebral development.

Main Methods:

• Embryonic zebrafish model used for small molecule screening.
• Screening parameters included varying concentration, genotype, and timing.
• Compounds were tested in multiple interrelated conditions to identify hits missed by standard designs.

Main Results:

• The modular screen recovered three times more compounds compared to standard screening designs.
• Identified molecular pathways and segmentation phenotypes relevant to human disorders.
• Generated an open-access annotated database of screening hits and associated data.

Conclusions:

• The modular screening strategy enhances hit frequency and compound discovery from chemical libraries.
• This approach provides valuable insights into human vertebral segmentation disorders and myopathies.
• The methodology is adaptable for diverse developmental biology questions and disease modeling.